The liquid dietary supplements market accounted for $21,685.72 million in 2019, and is expected to reach $27,732.27 million by 2027, registering a CAGR of 4.0% from 2020 to 2027.
Report Code : A10236 | Pages : 241 | Category : Life Sciences
The global ankylosing spondylitis market size was valued at $5,140.94 million in 2020, and is projected to reach $8,110.59 million by 2030, registering a CAGR of 4.6% from ...
Report Code : A10266 | Pages : 220 | Category : Life Sciences
The European Antibiotics Market size was valued at $11,561.2million in 2019, and is projected to reach $13,529.8million by 2027 at a CAGR of 1.9% from 2020 to 2027.
Report Code : A10311 | Pages : 181 | Category : Life Sciences
The Gulf Pain Management Drugs Market size was valued at $851.08 million in 2019, and is projected to reach $1,047.91 million by 2027, registering a CAGR of 3.2%.
Report Code : A10353 | Pages : 159 | Category : Life Sciences
The global vertebroplasty and kyphoplasty market was valued at $757.1 million in 2021, and is projected to reach $1,308.1 million by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Report Code : A10444 | Pages : 183 | Category : Life Sciences
The global women health and beauty supplements market size was valued at $57,280.90 million in 2020, and is expected to reach $206,885.20 million by 2030 at a CAGR ...
Report Code : A10448 | Pages : 245 | Category : Life Sciences
The global nanotechnology drug delivery market was valued at $87.5 billion in 2022, and is projected to reach $209.5 billion by 2032, growing at a CAGR of 9.1% from 2023 to 2032.
Report Code : A10459 | Pages : 245 | Category : Life Sciences
The global antiplatelet market was valued at $3.8 billion in 2022, and is projected to reach $5.8 billion by 2032, growing at a CAGR of 4.2% from 2023 to 2032.
Report Code : A10479 | Pages : 259 | Category : Life Sciences
The global sarcopenia treatment market size was valued at $2,577 million in 2020, and is projected to reach $4,704 million by 2030, registering a CAGR of 6.1% from ...
Report Code : A10526 | Pages : 239 | Category : Life Sciences
The global overactive bladder treatment market was valued at $2.4 billion in 2021, and is projected to reach $3.5 billion by 2031, growing at a CAGR of 3.6% from 2022 to 2031.
Report Code : A10543 | Pages : 268 | Category : Life Sciences
The global rapid acting insulin market size was valued at $7,100 million in 2019, and is projected to reach $8,925 million by 2027 at a CAGR of 4.1% from 2020 to 2027.
Report Code : A10599 | Pages : 168 | Category : Life Sciences
The global amino acid metabolism disorders treatment market was valued at $630.9 million in 2021, and is projected to reach $961.8 million by 2031, growing at a CAGR of 4.3% from 2022 to 2031.
Report Code : A10868 | Pages : 350 | Category : Life Sciences
The global retinal biologics market was valued at $14.9 billion in 2022, and is projected to reach $24.7 billion by 2032, growing at a CAGR of 5.1% from 2023 to 2032.
Report Code : A10946 | Pages : 243 | Category : Life Sciences
The global breast cancer drugs market was valued at $26.4 billion in 2022, and is projected to reach $59.3 billion by 2032, growing at a CAGR of 8.4% from 2023 to 2032.
Report Code : A11123 | Pages : 252 | Category : Life Sciences
The global complementary and alternative medicine market was valued at $102 billion in 2021, and is projected to reach $437.9 billion by 2031, growing at a CAGR of 15.6% from 2022 to 2031.
Report Code : A11182 | Pages : 342 | Category : Life Sciences
The global myasthenia gravis treatment market was valued at $1.7 billion in 2022, and is projected to reach $3.1 billion by 2032, growing at a CAGR of 6.5% from 2023 to 2032.
Report Code : A11194 | Pages : 263 | Category : Life Sciences
The global peptide therapeutics market was valued at $33.3 billion in 2021, and is projected to reach $64.3 billion by 2031, growing at a CAGR of 6.8% from 2022 to 2031.
Report Code : A11226 | Pages : 309 | Category : Life Sciences
The global macular degeneration treatment market was valued at $14.3 billion in 2023, and is projected to reach $30.9 billion by 2033, growing at a CAGR of 8.2% from 2024 to 2033.
Report Code : A11216 | Pages : 295 | Category : Life Sciences
The global pigmentation disorder treatment market was valued at $799.8 million in 2021, and is projected to reach $1,220.91 million by 2031, growing at a CAGR of 4.3% from 2022 to 2031.
Report Code : A11229 | Pages : 275 | Category : Life Sciences
The global pneumonia therapeutics market size was valued at $12,293.9 million in 2020, and is projected to reach $25,546.8 million by 2030, registering a CAGR of 8.5% from ...
Report Code : A11230 | Pages : 208 | Category : Life Sciences
The global artificial cornea and corneal implant market generated $376.61 million in 2020 and is projected to reach $656.19 million by 2028, growing at a CAGR of 7.9% from 2021 to 2028.
Report Code : A11333 | Pages : 215 | Category : Life Sciences
The global autologous cell therapy market was valued at $4.3 billion in 2021, and is projected to reach $29.1 billion by 2031, growing at a CAGR of 21% from 2022 to 2031.
Report Code : A11534 | Pages : 188 | Category : Life Sciences
The global tablet coatings market was valued at $2.2 billion in 2021, and is projected to reach $4.1 billion by 2031, growing at a CAGR of 6.6% from 2022 to 2031.
Report Code : A11539 | Pages : 286 | Category : Life Sciences
The global novel vaccine delivery systems market size was valued at $5,030 million in 2020 and is projected to reach $14,437 million by 2030 registering a CAGR of 10.8% from 2021 to 2030.
Report Code : A11784 | Pages : 208 | Category : Life Sciences
The global monoclonal antibodies market size was valued at $146,642 million in 2020, and is projected to reach $390,582 million by 2030, registering a CAGR of 10.2% from 2021 to 2030.
Report Code : A11789 | Pages : 245 | Category : Life Sciences
